Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof

Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof

US Patent 11345904 · Granted May 31, 2022

Estimated economic value: $94,660,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of c-type natriuretic peptide variants to treat osteoarthritis2025
Anti-CD70 antibody drug conjugates2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified relaxin polypeptides and their uses2023
Anti-CD70 antibody drug conjugates2022
Nucleic acids encoding modified relaxin polypeptides2022
Compositions containing, methods involving, and uses of non-natural amino acid l2022
Methods of treating heart failure and fibrotic disorders using modified relaxin 2022
TPP-1 formulations and methods for treating CLN2 disease2022
Use of C-type natriuretic peptide variants to treat osteoarthritis2021
Modified FGF-21 polypeptides and their uses2021
Compositions containing, methods involving, and uses of non-natural amino acid l2021